BioNTech

COVID Vax Weaker Against Omicron, Possibly All Variants: Johns Hopkins, NIAID, NIH

"Antibodies produced by vaccinated and boosted people may not stop omicron SARS-CoV-2 strain from entering cells as well as it stops original virus," say Johns Hopkins researchers.

Biden Stumbles With Suburban Women and Mothers Before Midterm Elections

From parental rights regarding school curricula to COVID-19 vaccine authorization delays for children younger than 5, President Joe Biden and Democrats are frustrating suburban mothers.

769 Athletes Collapsed This Year During Competition. What’s Going On?

More than 769 athletes have collapsed on the field during a game from March 2021 to March 2022.

Son Describes Mother’s Death After Moderna Shot

In an exclusive interview with The Defender, Jeffrey Beauchine said his mother, Carol, knew her Creutzfeldt-Jakob Disease was related to the Moderna shot. Watching her death was like “something you see out of a movie,” he said.

Pfizer Document Reveals Company Hired 600 Workers to Address Spike in Adverse Reaction Reports

Pfizer is required to release a certain number of vaccine-related documents each month

The Real Reason They Want to Give COVID Jabs to Kids

In this interview, Alix Mayer explains why our children are being so aggressively targeted for the COVID-19 injection even though they’re not at risk of serious SARS-CoV-2 infection, and clarifies the status of Comirnaty.

In Lab Study, Pfizer Vaccine Showed Potential to Alter DNA in Human Liver Cells, but Scientists Caution More Research Needed

Swedish researchers showed the mRNA from the Pfizer COVID-19 vaccine can be reverse-transcribed into DNA in human liver cells in vitro, but more research is needed to determine if this transcribed vaccine-derived DNA can integrate into human genomic DNA.

44 Studies on Vaccine Efficacy That Raise Doubts on Vaccine Mandates

As some people have now been vaccinated for more than half a year, evidence is pouring in about Covid vaccine efficacy.

Pfizer Pushes for 4th Shot, Says 3 Doses ‘Not That Good’ Against Infections

Pfizer CEO Albert Bourla on Sunday said the vaccine maker plans to submit data on a fourth dose of its COVID-19 vaccine to the U.S. Food and Drug Administration because protection after three doses is “not that good against infections” and “doesn’t last very long” when faced with a variant like Omicron.

New Data Show Only 12% of Kids Taking Pfizer’s Vax Were Protected Against COVID: N.Y. State Department

Newly released BioNTech data shows that only a little more than 1 in 10 kids who took Pfizer’s COVID-19 vaccine were protected against the Omicron variant.

Latest news

- Advertisement -spot_img